Chinese Traditional and Herbal Drugs
|
2025, 56(7): 2469-2481
Visualization analysis of patents related to traditional Chinese medicine from global perspective
Full
GUO Xiaopeng1, GUO Bochi2, WU Lingyan2, TENG Shuangshuang2, REN Qingling1, SHU Yachun3,1
Affiliations
1 Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Provincial hospital of Chinese Medicine, Nanjing 210029, China;
2 Ourchem Intellectual Property Service Co., Ltd., Nanjing 211100, China;
3 Jiangsu Province Seaside Rehabilitation Hospital, Lianyungang 222042, China
doi: 10.7501/j.issn.0253-2670.2025.07.021
Outline
Objective Patyee database was used to visually analyze the research patent situation of Chinese materia medica (CMM) in recent years. Methods From the perspective of global patents, this article conduct a detailed analysis of the technological development status of CMM, it delves into patent applications pertaining to active pharmaceutical ingredients (APIs), final products, and the utilization of CMM worldwide, with a particular focus on China. Results The number of patent applications in the global CMM has been in the state of high application volume, and the geographical distribution shows that the main source and application countries of CMM technology are both China. Among them, the number of CMM patent applications in China is in an absolute dominant position, but the effective rate is the lowest among the major applicant countries. The analysis of global patents of CMM in the fields of APIs, finished medicines and applications shows that the number of patents forfinished medicines far exceeds that forAPIs and applications, and China absolutely leads in the number of patents in each technical branch. The analysis of Chinese patents of CMM in the fields of APIs, finished medicines and applications shows that the number of patents forfinished medicines is the highest, followed by applications, and the number of patents for APIs is the lowest. Conclusion Although the volume of domestic patent applications related to CMM far exceeds that of overseas, it still faces problems such as relatively low patent quality, insufficient overseas patent layout, and unbalanced distribution of patents among APIs, finished products and applications, etc. It is suggested that the relevant innovation bodies need to lay out their research and development in a more targeted manner to enhance the height of innovation.
Chinese materia medica
/
traditional Chinese medicine
/
Patyee
/
patent analysis
/
visualization
郭孝鹏, 郭泊池, 吴玲燕, 滕爽爽, 任青玲, 束雅春.
全球视角下中药相关专利的可视化分析.
中草药,
2025
, 56
(7)
: 2469
-2481
.
DOI: 10.7501/j.issn.0253-2670.2025.07.021
GUO Xiaopeng, GUO Bochi, WU Lingyan, TENG Shuangshuang, REN Qingling, SHU Yachun.
Visualization analysis of patents related to traditional Chinese medicine from global perspective[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(7)
: 2469
-2481
.
DOI: 10.7501/j.issn.0253-2670.2025.07.021
Year 2025 volume 56 Issue 7
37
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.07.021
- Receive Date:2024-11-21
- Online Date:2026-11-13